Organ ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours

ConclusionAs the “wait‐and‐see” policy can be not useful due to uncontrolled disease progression, choice of organ‐preserving treatment first can become the first line of decision taking in small benign pNETs. Our experience shows that organ‐preserving treatment is more comfortable for the surgeon and for the patient. However, it is not the universal position. The long‐term survival data still has to be estimated.

Source: Surgical Practice - January 12, 2021 Category: Surgery Authors: Andrey G. Kriger, Stanislav V. Berelavichus, Ayrat R. Kaldarov, David S. Gorin, Marianna B. Raevskaya, Vladimir V. Kazennov, Vita Y. Zekster, Vladimir I. Panteleev Tags: ORIGINAL ARTICLE Source Type: research